Literature DB >> 26468355

Histopathology diagnosis of coeliac disease - clinicopathological correlation is key!

Marjorie M Walker1.   

Abstract

Entities:  

Year:  2015        PMID: 26468355      PMCID: PMC4600525     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol Bed Bench        ISSN: 2008-2258


× No keyword cloud information.
To The Editor: A robust diagnosis of coeliac disease is paramount for patient and clinician. The recent paper and subsequent editorial in this journal emphasises this point (1,2). However there is little mention of recent evidence based international guidelines in considering which classifications to use (3-5). These guidelines are carefully considered by the authors, have undergone rigorous review and are backed by the literature and outline both definitions of coeliac disease (3) and guidelines for diagnosis and management (4, 5). Why is it so important to make a cast iron diagnosis in coeliac disease? For the patient, treatment with a gluten free diet is costly, socially restricting and difficult, as many foods may have hidden gluten. For the clinician, the responsibility lies in prevention of future complications, ranging from the consequences of malabsorption such as osteoporosis to a possible malignant outcome. It is important that histopathologists, in tandem with clinicians, make an early diagnosis. For histopathology the difficulties often lie in making this diagnosis at an early stage. Two studies underline the importance of suggesting coeliac disease when the histopathological features do not include flat mucosa (6, 7). Patients with mild enteropathy may experience clear gluten-induced symptoms and benefit from a gluten free diet (6) and also have weight loss, anaemia, folate deficiency, hyperparathyroidism and evidence of osteoporosis (7). Aside from performing serology (and where needed HLA testing), endoscopists should take enough biopsies to allow us to make the diagnosis – at least 4-6, including duodenal bulb – to make a diagnosis as this increases the chance to spot early and histological features(8). We should also be mindful that normal architecture and ≥25 IELs/ 100 enterocytes (lymphocytic duodenosis (4) can represent coeliac disease in some patients, given the right clinico-pathological setting. Histopathologists should suggest this diagnosis when there is no current serology / HLA typing available to prompt these inveatigations. Although many other conditions are associated with LD (4,9), we must not ignore this finding. Mild enteropathy is not mild disease!
  9 in total

1.  Increasing duodenal intraepithelial lymphocytosis found at upper endoscopy: time trends and associations.

Authors:  Eugenia Shmidt; Thomas C Smyrk; Christopher L Boswell; Felicity T Enders; Amy S Oxentenko
Journal:  Gastrointest Endosc       Date:  2014-02-22       Impact factor: 9.427

2.  The Oslo definitions for coeliac disease and related terms.

Authors:  Jonas F Ludvigsson; Daniel A Leffler; Julio C Bai; Federico Biagi; Alessio Fasano; Peter H R Green; Marios Hadjivassiliou; Katri Kaukinen; Ciaran P Kelly; Jonathan N Leonard; Knut Erik Aslaksen Lundin; Joseph A Murray; David S Sanders; Marjorie M Walker; Fabiana Zingone; Carolina Ciacci
Journal:  Gut       Date:  2012-02-16       Impact factor: 23.059

3.  Celiac disease with mild enteropathy is not mild disease.

Authors:  Barbara Zanini; Francesca Caselani; Alberto Magni; Daniele Turini; Alice Ferraresi; Francesco Lanzarotto; Vincenzo Villanacci; Nice Carabellese; Chiara Ricci; Alberto Lanzini
Journal:  Clin Gastroenterol Hepatol       Date:  2012-09-27       Impact factor: 11.382

4.  Adherence to biopsy guidelines increases celiac disease diagnosis.

Authors:  Benjamin Lebwohl; Robert C Kapel; Alfred I Neugut; Peter H R Green; Robert M Genta
Journal:  Gastrointest Endosc       Date:  2011-05-20       Impact factor: 9.427

5.  ACG clinical guidelines: diagnosis and management of celiac disease.

Authors:  Alberto Rubio-Tapia; Ivor D Hill; Ciarán P Kelly; Audrey H Calderwood; Joseph A Murray
Journal:  Am J Gastroenterol       Date:  2013-04-23       Impact factor: 10.864

6.  Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study.

Authors:  Kalle Kurppa; Pekka Collin; Mervi Viljamaa; Katri Haimila; Päivi Saavalainen; Jukka Partanen; Kaija Laurila; Heini Huhtala; Kaija Paasikivi; Markku Mäki; Katri Kaukinen
Journal:  Gastroenterology       Date:  2008-11-24       Impact factor: 22.682

Review 7.  Mucosal histopathology in celiac disease: a rebuttal of Oberhuber's sub-division of Marsh III.

Authors:  Michael N Marsh; Matt W Johnson; Kamran Rostami
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

8.  What is the best histopathological classification for celiac disease? Does it matter?

Authors:  Amado Salvador Peña
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

9.  Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology.

Authors:  Jonas F Ludvigsson; Julio C Bai; Federico Biagi; Timothy R Card; Carolina Ciacci; Paul J Ciclitira; Peter H R Green; Marios Hadjivassiliou; Anne Holdoway; David A van Heel; Katri Kaukinen; Daniel A Leffler; Jonathan N Leonard; Knut E A Lundin; Norma McGough; Mike Davidson; Joseph A Murray; Gillian L Swift; Marjorie M Walker; Fabiana Zingone; David S Sanders
Journal:  Gut       Date:  2014-06-10       Impact factor: 23.059

  9 in total
  3 in total

1.  Discriminant value of IEL counts and distribution pattern through the spectrum of gluten sensitivity: a simple diagnostic approach.

Authors:  Ayca Kirmizi; Cagdas Kalkan; Seher Yuksel; Zeynep Gencturk; Berna Savas; İrfan Soykan; Hulya Cetinkaya; Arzu Ensari
Journal:  Virchows Arch       Date:  2018-08-09       Impact factor: 4.064

2.  Letter to the Editor GHFBB; Response to Peña AS: What is the best histopathological classification for celiac disease? Does it matter?

Authors:  Olga M Pulido
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016

3.  Coeliac disease, mucosal change and IEL: doing what counts the best.

Authors:  Michael N Marsh
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.